KREBSBIO

Krebs Biochemicals & Industries Share PriceKrebs Biochemicals & Industries

₹81.45
3.85 (4.96%)
As on 09 December, 2023 | 00:03 BSE: 524518 NSE: KREBSBIOISIN: INE268B01013

Krebs Biochemicals & Industries Performance

Day Range

  • Low 77.60
  • High 81.45
₹ 81.45

52 Week Range

  • Low 50.65
  • High 120.25
₹ 81.45
  • Open Price77.60
  • Previous Close77.60
  • Volume16574

Start SIP in Krebs Biochemicals & Industries

Start SIP

Krebs Biochemicals & Industries Share Price

  • Over 1 Month -6.11%
  • Over 3 Month 26.48%
  • Over 6 Month 27.37%
  • Over 1 Year -30.92%

Krebs Biochemicals & Industries Key Statistics

P/E Ratio -8.2
PEG Ratio -0.2
Market Cap Cr 176
Price to Book Ratio -1.8
EPS -11.5
Dividend 0
Relative Strength Index 55.31
Money Flow Index 37.79
MACD Signal 1.3
Average True Range 4.06

Krebs Biochemicals & Industries Investment Rating

  • Master Rating:
  • Krebs Biocs.& Inds. has an operating revenue of Rs. 46.02 Cr. on a trailing 12-month basis. An annual revenue de-growth of -13% needs improvement, Pre-tax margin of -47% needs improvement, NULL The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 8% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart and is trading around -0% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 37 which is a POOR score indicating inconsistency in earnings, a RS Rating of 42 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 68 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Krebs Biochemicals & Industries Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 1511119211018
Operating Expenses Qtr Cr 16131612231729
Operating Profit Qtr Cr -1-3-5-3-2-7-11
Depreciation Qtr Cr 2212222
Interest Qtr Cr 1111100
Tax Qtr Cr 0000000
Net Profit Qtr Cr -4-5-7-6-4-8-11
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 5361
Operating Expenses Annual Cr 6894
Operating Profit Annual in Cr -16-34
Depreciation Cr 76
Interest Annual Cr 35
Tax Annual Cr 00
Net Profit Annual Cr -25-45
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr -17-17
Cash from Investing Activity Annual Cr -23-23
Cash from Financing Annual Activity Cr 4040
Net Cash Flow Annual Cr -1
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr -99-75
Fixed Assets Annual Cr 151147
Total Non Current Assets Annual Cr 159154
Total Current Assets Annual Cr 1635
Total Assets Annual Cr 175190
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs -46-35
ROE Annual % 00
ROCE Annual % -17-35
Total Debt to Total Equity Annual --
EBDIT Annual Margin % -29-55
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Krebs Biochemicals & Industries Technicals

EMA & SMA

Current Price
₹81.45
3.85 (4.96%)
pointer
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹79.65
  • 50 Day
  • ₹76.92
  • 100 Day
  • ₹74.91
  • 200 Day
  • ₹78.49
  • 20 Day
  • ₹80.71
  • 50 Day
  • ₹75.90
  • 100 Day
  • ₹72.60
  • 200 Day
  • ₹71.17

Krebs Biochemicals & Industries Resistance and Support

PIVOT
₹80.17
Resistance
First Resistance 82.73
Second Resistance 84.02
Third Resistance 86.58
RSI 55.31
MFI 37.79
MACD Single Line 1.30
MACD 0.71
Support
First Resistance 78.88
Second Resistance 76.32
Third Resistance 75.03

Krebs Biochemicals & Industries Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 41,992 3,061,637 72.91
Week 27,427 1,834,866 66.9
1 Month 24,231 1,294,160 53.41
6 Month 22,173 1,478,522 66.68

Krebs Biochemicals & Industries Result Highlights

Krebs Biochemicals & Industries Synopsis

NSE-Medical-Generic Drugs

Krebs Biochemicals & belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 52.13 Cr. and Equity Capital is Rs. 21.56 Cr. for the Year ended 31/03/2023. Krebs Biochemicals & Industries Ltd. is a Public Limited Listed company incorporated on 02/12/1991 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24110AP1991PLC103912 and registration number is 103912.
Market Cap 176
Sales 46
Shares in Float 0.58
No of funds 5
Yield
Book Value -10.12
U/D Vol ratio 1.7
LTDebt / Equity
Alpha -0.14
Beta 1.11

Krebs Biochemicals & Industries

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 72.74%72.74%72.74%72.72%
Foreign Portfolio Investors 0.5%0.5%0.5%0.33%
Individual Investors 18.8%18.54%18.58%18.68%
Others 7.96%8.22%8.18%8.27%

Krebs Biochemicals & Industries Management

Name Designation
Dr. R T Ravi Chairman & Non-Exe.Director
Mr. Pabitrakumar Kalipada Bhattacharyya Managing Director
Mr. Jitendra Shah Non Executive Director
Mr. G V L Prasad Independent Director
Mr. Raj Kamal Prasad Verma Independent Director
Dr. Tangirala Malati Independent Director
Mr. Satish Khivsara Independent Director
Mr. Avinash Ravi Non Executive Director

Krebs Biochemicals & Industries Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Krebs Biochemicals & Industries Corporate Action

Date Purpose Remarks
2023-11-08 Quarterly Results
2023-08-09 Quarterly Results
2023-05-24 Audited Results
2023-02-03 Quarterly Results
2022-11-10 Quarterly Results

Krebs Biochemicals & Industries FAQs

What is Share Price of Krebs Biochemicals & Industries ?

Krebs Biochemicals & Industries share price is ₹81 As on 08 December, 2023 | 23:49

What is the Market Cap of Krebs Biochemicals & Industries ?

The Market Cap of Krebs Biochemicals & Industries is ₹175.6 Cr As on 08 December, 2023 | 23:49

What is the P/E ratio of Krebs Biochemicals & Industries ?

The P/E ratio of Krebs Biochemicals & Industries is -8.2 As on 08 December, 2023 | 23:49

What is the PB ratio of Krebs Biochemicals & Industries ?

The PB ratio of Krebs Biochemicals & Industries is -1.8 As on 08 December, 2023 | 23:49

Q2FY23